Biospecimen Collection

SEP 9, 2026 · PHASE 2 TRIAL

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

ClinicalTrials.gov

Phase 2 trial in a vulnerable population with immunosuppression; registry record reports no results, only planned design and enrollment completion.

SEP 4, 2026 · PHASE 3 TRIAL

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

ClinicalTrials.gov

This is an active Phase 3 trial registration with no results posted; the study design is sound but outcome data are not yet available, making any evidence claim premature.

AUG 20, 2026 · PHASE 2 TRIAL

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

ClinicalTrials.gov

Phase 2 interventional trial testing a mechanistic hypothesis (inflammation reduction) as surrogate for cancer prevention in an unstudied population; no results reported in registry record.

AUG 20, 2026 · PHASE 2 TRIAL

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

ClinicalTrials.gov

Phase 2 trial in a recruiting stage with no results reported; measures a surrogate endpoint (ctDNA clearance) in an adjuvant minimal residual disease setting.

AUG 20, 2026 · PHASE 2 TRIAL

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

ClinicalTrials.gov

This is a Phase 2 trial still recruiting with no results posted; it represents early-phase investigation of lutetium Lu 177 dotatate versus everolimus in bronchial neuroendocrine tumors.

AUG 19, 2026 · PHASE 2 TRIAL

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

ClinicalTrials.gov

This is a Phase 2 trial registration with no results reported; the study is still recruiting and no efficacy or safety data are available.

AUG 19, 2026 · PHASE 3 TRIAL

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for analysis.

AUG 18, 2026 · PHASE 1 TRIAL

Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

ClinicalTrials.gov

Phase 1 trial of a three-drug combination in metastatic breast cancer with dose-limiting toxicity as the primary endpoint; no results posted in this registry record.